Read the First Edition of The Lens, a new magazine by LSI arrow
104 LSI USA24 DAY 2 EVE large

Nov 4, 2024

BCI Technologies: Neurotechnology to Address Limitations of the Human Body

At a panel at LSI USA '24, the discussion around brain-computer interfaces (BCIs) highlighted their transfo...

Read More next
20 03 24 LSI DAY 2 (ADAM) 0787 large

Nov 3, 2024

International Expansion, Market Development, and Cross-Border Partnerships in the US, EU, and APAC | Insights from LSI USA ‘24

A panel at LSI USA ‘24 brought together industry leaders to explore strategies for expanding internat...

Read More next
LSI Track 4 Day 2 512 large
Nov 1, 2024

Harsh Realities in Building and Financing Medtech Ventures | Insights from LSI USA ‘24
next
LSI Track 4 Day 3 492 large
Oct 23, 2024

Insights from LSI USA ‘24 | Investing for the Long-Haul: Supporting Companies and Aligning Investors Across Stages
next
LSI Track 4 Day 3 534 large
Oct 22, 2024

Insights from LSI USA ‘24: What Does 2024 Hold For the Frozen IPO Market?
next
insights from lsi usa 24 ip friend or foe in building medtech ventures
Oct 18, 2024

Insights from LSI USA ‘24 | IP: Friend or Foe in Building Medtech Ventures?
next
LSI Track 4 Day 3 109 large
Oct 3, 2024

Insights from LSI USA '24: The Verticalization of AI in Medtech and Healthcare
next
blog
Sep 24, 2024

Insights from LSI USA '24: The Agony and Ecstasy of Doing Big Things in Medtech
next
lab_to_market
Sep 11, 2024

Insights From LSI USA ‘24: Bridging the Gap Between Academia and Industry
next
medtech_investors_lsi_usa
Sep 10, 2024

Insights From LSI USA ‘24: Medtech Growth Capital and the New Normal in Late-Stage Financing
next
medtech_ma_USA_24
Sep 6, 2024

Insights From LSI USA ‘24: Medtech M&A 2024, Looking Onward and Upward
next
LSI_USA_Stryker_MA_strategy
Sep 5, 2024

Insights from LSI USA ‘24: Stryker’s Journey to $20 Billion and the Role of M&A
next